A study on telomerase activity and prognosis in breast cancer

There are still many questions to be elucidated concerning the relationship between telomerase activity and various factors associated with cancer. Whether or not the level of telomerase activity could be a prognostic factor in breast cancer was investigated through 5-yr follow-up observation. Telom...

Full description

Saved in:
Bibliographic Details
Published in:Medical oncology (Northwood, London, England) London, England), 2003-01, Vol.20 (2), p.117-126
Main Authors: Kimura, M, Koida, T, Yanagita, Y
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Combined Chemotherapy Protocols
Breast cancer
Breast Neoplasms - enzymology
Breast Neoplasms - therapy
Chemotherapy, Adjuvant
Female
Humans
Middle Aged
Oncology
Prognosis
Regression Analysis
Survival Analysis
Telomerase - metabolism
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There are still many questions to be elucidated concerning the relationship between telomerase activity and various factors associated with cancer. Whether or not the level of telomerase activity could be a prognostic factor in breast cancer was investigated through 5-yr follow-up observation. Telomerase activity was quantified by the fluorescence-based telomeric repeat amplification protocol assay in 54 patients with breast cancer and its relationship with patient prognosis was examined. Telomerase activity was detected in 92.6% of breast cancer patients, with a median of 65.4 TPG (total product generated) (Min 0-Max 446.2). The follow-up observation for 5 yr demonstrated that among background factors examined, recurrence was the only factor that showed a significant association with the level of telomerase activity when a cutoff at 100 TPG was adopted. This suggested the possibility of 100 TPG telomerase activity being a prognostic factor for recurrence. Prospective studies will be necessary to clarify this matter.
ISSN:1357-0560
1357-0560
1559-131X
DOI:10.1385/mo:20:2:117